NCT00254267View on ClinicalTrials.gov

Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors

PHASE2CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

December 31, 2012

Conditions

Advanced Gastrointestinal Stromal Tumor

Interventions

DRUG

AMG 706

AMG 706 125mg, oral, once a day

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Takeda

INDUSTRY

lead

Amgen

INDUSTRY

NCT00254267 - Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors | Biotech Hunter | Biotech Hunter